COVAXIN Current Affairs, GK & News
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..
Month: Current Affairs - January, 2021
Category: Science & Technology Current Affairs
Topics: Bharat Biotech • COVAXIN • Covishield • DGCI • Emergency Use Authorisation • HGCO19 • ICMR • SPUTNIK V • ZyCov-D
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..
Month: Current Affairs - January, 2021
Category: India Nation & States Current Affairs
Topics: AstraZeneca • Bharat Biotech Limited • Clinical trials • COVAXIN • COVAXIN Vaccine • COVID-19 vaccine • Covishield • Director controller General of India • Serum Institute of India
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..
Month: Current Affairs - November, 2020
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • COVAXIN • COVAXIN Vaccine • ICMR • Moderna • National Institute of Virology • Pfizer • SPUTNIK V
Mission COVID Suraksha: Key Facts
On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not cover the cost and distribution of the vaccines. Key Highlights The mission is a part ..
Month: Current Affairs - November, 2020
Category: Economy & Banking Current Affairs
Topics: Atma Nirbhar Bharat Rozgar Yojana • COVAX • COVAXIN • Covishield • GAVI • Mission COVID Suraksha • SPUTNIK V • World Trade Organisation • ZyCov-D
India-Bangladesh sign MoU on COVID-19 Vaccine
On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights According to the agreement, initially 1.5 crore people will be vaccinated as each person requires ..
Month: Current Affairs - November, 2020
Category: International Current Affairs
Topics: Bharat Biotech • COVAX • COVAXIN • COVID-19 vaccine • Covishield • eVIN • GAVI • ICMR • India-Bangladesh • Serum Institute of India